Juan Antonio Riesco

TL;DR: The original severity classification has been replaced by a much simpler risk classification (low or high risk), on the basis of lung function, dyspnea grade, and history of exacerbations, while determination of clinical phenotype is recommended only in high-risk patients.

TL;DR: The severity classification and the pharmacological treatment of stable COPD are described and GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients.

TL;DR: This research presents a meta-anatomy of the neumologia and physiology of the connective tissue of the autonomic nervous system, which has been studied in detail in the context of chronic illness and rehabilitation.

TL;DR: The severity classification and the pharmacological treatment of stable COPD are described and GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients.

TL;DR: Servicio de Neumología, Hospital Universitari Vall d’Hebron, Barcelona, España CIBER de Enfermedades Respiratorias, Servicio de Medicina Interna, Hospital de Requena, Valencia; Instituto de Investigación Sanitaria Princesa (IP).